Approval · Notice of Compliance 18265 · 2016
EPCLUSA: Notice of Compliance 18265
Issued July 11, 2016
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 18265
- Date
- July 11, 2016
- Company
- Gilead Sciences Canada IncMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Priority-NAS
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| EPCLUSA | 02456370 | Marketed |
Medicinal ingredients
- SOFOSBUVIR 400 MG per TAB
- VELPATASVIR 100 MG per TAB